InvestorsObserver
×
News Home

Where Does Adverum Biotechnologies Inc (ADVM) Stock Fall in the Biotechnology Field After It Has Fallen -14.97% This Week?

Monday, March 25, 2024 12:25 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Adverum Biotechnologies Inc (ADVM) Stock Fall in the Biotechnology Field After It Has Fallen -14.97% This Week?

The 63 rating InvestorsObserver gives to Adverum Biotechnologies Inc (ADVM) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 74 percent of stocks in the Biotechnology industry, ADVM’s 63 overall rating means the stock scores better than 63 percent of all stocks.

Overall Score - 63
ADVM has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on ADVM!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Adverum Biotechnologies Inc Stock Today?

Adverum Biotechnologies Inc (ADVM) stock is trading at $15.05 as of 12:24 PM on Monday, Mar 25, a drop of -$1.01, or -6.29% from the previous closing price of $16.06. The stock has traded between $15.01 and $16.43 so far today. Volume today is 184,834 compared to average volume of 221,770. Click Here to get the full Stock Report for Adverum Biotechnologies Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App